XML 54 R20.htm IDEA: XBRL DOCUMENT v2.4.0.6
Note 6 - Stockholders' Equity: (Tables)
3 Months Ended
Sep. 30, 2012
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
 

Weighted

average,

June 30, 2012

Range,

June 30, 2012

Weighted

average,

June 30, 2011

Range,

June 30, 2011

Volatility

    66 %   60% - 68%     84 %     61% - 88%

Dividend yield

    -     -     -     -

Risk-free interest rate

    0.32 %   0.31% - 0.34%     1.37 %     0.25% - 2.02%

Expected term (years)

    3.05   2.66 - 3.25     4.1     2 - 4.5
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]
 

Options

Weighted-

Average

Exercise

Price

Weighted-

Average

Remaining

Contractual

Life

Aggregate

Intrinsic

Value

Outstanding at July 1, 2012

    5,111,145     2.86     4.6     274,200

Granted

    150,000     2.10                

Exercised

    -     -                

Forfeited

    -     -                

Expired

    -     -                

Outstanding at September 30, 2012

    5,261,145   $ 2.84     4.4   $ 206,250

Exercisable at September 30, 2012

    4,671,145   $ 2.85     4.2   $ 206,250
Schedule of Nonvested Share Activity [Table Text Block]
 

Options

Weighted Average

Grant-Date Fair

Value

Nonvested at July 1, 2011

    590,000   $ 1.83

Granted

    150,000     0.83

Vested

    (150,000 )     (0.83 )

Forfeited

    -     -

Nonvested at June 30, 2012

    590,000   $ 1.83
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]
 

Three months ended September 30, 2012

Three months ended September 30, 2011

General and administrative:

               

Fair value of stock/warrant bonuses expensed

  $ 1,151,250   $ 1,035,300

Fair value of stock issued to an employee

    24,999     24,999

Change in fair value from modification of option terms

    -     94,820

Fair value of stock options expensed

    230,353     1,846,265

Total

  $ 1,406,602   $ 3,001,384
                 

Research and development:

               

Fair value of stock options expensed

  $ 8,702   $ 40,598

Total

  $ 8,702   $ 40,598